NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 215 filers reported holding NEVRO CORP in Q4 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $60,774 | -4.1% | 3,162 | +26.8% | 0.00% | 0.0% |
| Q2 2023 | $63,397 | +192012.1% | 2,494 | +170.8% | 0.00% | +100.0% |
| Q1 2023 | $33 | -80.0% | 921 | -77.9% | 0.00% | -85.7% |
| Q4 2022 | $165 | -99.9% | 4,174 | +51.3% | 0.01% | +250.0% |
| Q3 2022 | $128,000 | -23.8% | 2,759 | -28.0% | 0.00% | -50.0% |
| Q2 2022 | $168,000 | +0.6% | 3,833 | +65.9% | 0.00% | +100.0% |
| Q1 2022 | $167,000 | -41.0% | 2,310 | -33.7% | 0.00% | -60.0% |
| Q4 2021 | $283,000 | +27.5% | 3,486 | +82.9% | 0.01% | -16.7% |
| Q3 2021 | $222,000 | +58.6% | 1,906 | +125.0% | 0.01% | +50.0% |
| Q2 2021 | $140,000 | -94.0% | 847 | -95.0% | 0.00% | -90.0% |
| Q1 2021 | $2,350,000 | +843.8% | 16,843 | +1072.1% | 0.04% | +400.0% |
| Q4 2020 | $249,000 | -93.2% | 1,437 | -94.5% | 0.01% | -80.5% |
| Q3 2020 | $3,660,000 | +380.3% | 26,270 | +311.9% | 0.04% | +32.3% |
| Q2 2020 | $762,000 | +9425.0% | 6,378 | +7492.9% | 0.03% | – |
| Q1 2020 | $8,000 | -33.3% | 84 | -20.8% | 0.00% | -100.0% |
| Q4 2019 | $12,000 | +50.0% | 106 | -47.0% | 0.00% | 0.0% |
| Q4 2018 | $8,000 | -96.8% | 200 | -95.4% | 0.00% | -94.4% |
| Q3 2018 | $248,000 | +3442.9% | 4,341 | +4723.3% | 0.02% | – |
| Q2 2018 | $7,000 | -89.1% | 90 | -87.9% | 0.00% | -100.0% |
| Q1 2018 | $64,000 | +178.3% | 741 | +125.9% | 0.01% | +66.7% |
| Q4 2017 | $23,000 | -92.2% | 328 | -89.8% | 0.00% | -87.5% |
| Q3 2017 | $293,000 | +61.0% | 3,220 | +65.7% | 0.02% | +33.3% |
| Q1 2017 | $182,000 | +180.0% | 1,943 | +118.8% | 0.02% | +157.1% |
| Q4 2016 | $65,000 | -28.6% | 888 | -28.0% | 0.01% | -22.2% |
| Q2 2016 | $91,000 | +1416.7% | 1,233 | +1133.0% | 0.01% | +800.0% |
| Q1 2016 | $6,000 | -14.3% | 100 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $7,000 | -50.0% | 100 | -67.4% | 0.00% | 0.0% |
| Q3 2015 | $14,000 | +250.0% | 307 | +298.7% | 0.00% | – |
| Q2 2015 | $4,000 | -84.6% | 77 | -85.9% | 0.00% | -100.0% |
| Q1 2015 | $26,000 | +550.0% | 546 | +446.0% | 0.00% | – |
| Q4 2014 | $4,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
| Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
| Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
| Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
| PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
| Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
| Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
| Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
| HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
| FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |